Certified by Founder Lodge
5AM Ventures
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $100,000,000
16 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within
| Company | Date | Round | Raised |
|---|---|---|---|
Karius |
May, 03 ,2024 | Series C | $100,000,000 |
Karius |
May, 03 ,2024 | Series C | $100,000,000 |
TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
Renasant Bio |
July, 11 ,2025 | Seed | $54,500,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Fellow |
July, 16 ,2025 | Series B | $24,000,000 |
TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
Renasant Bio |
July, 11 ,2025 | Seed | $54,500,000 |
Radionetics Oncology |
January, 04 ,2024 | Series A | $52,500,000 |
Latigo Biotherapeutics, Inc. |
February, 15 ,2024 | Series A | $135,000,000 |
Karius |
May, 03 ,2024 | Series C | $100,000,000 |
TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
Renasant Bio |
July, 11 ,2025 | Seed | $54,500,000 |
Fellow |
July, 16 ,2025 | Series B | $24,000,000 |
Karius
TMRW Life Sciences
CAMP4 Therapeutics
Renasant Bio
Ensoma
Fellow
MapLight Therapeutics, Inc.
Radionetics Oncology
Latigo Biotherapeutics, Inc.
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)